NA-101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNA-101
Drug Alias NameNA-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalpain-2 catalytic subunit inhibitors
TargetsCalpain-2 catalytic subunit
Therapy Area/IndicationsGlaucomaStrokeBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWestern University Of Health Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurAegis Inc
Active IndicationsN/A
Inactive IndicationsGlaucomaStrokeBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A